Ester Amado
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 11
-
- Medication Adherence and Compliance 5
- Co-authors
- Enriqueta Pujol‐RiberaJosep M. BorràsPérez RodríguezConcepción ViolánJosé Luis del Val GarcíaValeria Pacheco‐HuergoAlbert Roso‐LlorachMontserrat Núñez
- Journals
- Journal of Antimicrobial Chemotherapy (1 paper)Journal of Clinical Medicine (1 paper)BMC Public Health (1 paper)Journal of Innovation in Health Informatics (1 paper)Diabetes Care (1 paper)
- Partner nations
- Spain
In The Last Decade
Ester Amado
23 papers receiving 283 citations
Peers
Comparison fields: 5 of 73
- Family Practice 56
- Geriatrics and Gerontology 80
- Applied Microbiology and Biotechnology 18
- General Health Professions 75
- Cardiology and Cardiovascular Medicine 57
Countries citing papers authored by Ester Amado
This map shows the geographic impact of Ester Amado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Amado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Amado more than expected).
Fields of papers citing papers by Ester Amado
This network shows the impact of papers produced by Ester Amado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Amado. The network helps show where Ester Amado may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester Amado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2023 | 1 | |
| 3 | 2020 | 26 | |
| 4 | 2020 | 15 | |
| 5 | 2018 | 2 | |
| 6 | 2017 | 10 | |
| 7 | 2015 | 10 | |
| 8 | 2015 | 2 | |
| 9 | 2014 | 7 | |
| 10 | 2013 | 3 | |
| 11 | 2013 | 6 | |
| 12 | Prescripció farmacèutica segura (PREFASEG) | 2011 | 3 |
| 13 | 2011 | 53 | |
| 14 | 2011 | 55 | |
| 15 | 2009 | 10 | |
| 16 | 2008 | 4 | |
| 17 | 2004 | 29 | |
| 18 | 2000 | 10 | |
| 19 | [Is the profile of antihypertensive drug utilization justified?]. | 1997 | 4 |
| 20 | 1986 | 5 |
About Ester Amado
Ester Amado is a scholar working on Geriatrics and Gerontology, Family Practice, Issues, ethics and legal aspects, Applied Microbiology and Biotechnology and Toxicology, having authored 23 papers that have together received 295 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Disease Management Strategies (6 papers), Medication Adherence and Compliance (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical studies and practices (2 papers), Pharmaceutical industry and healthcare (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Biomedical Text Mining and Ontologies (2 papers). The work is most often cited by research in Family Practice (56 citations), Geriatrics and Gerontology (80 citations), Applied Microbiology and Biotechnology (18 citations), General Health Professions (75 citations) and Cardiology and Cardiovascular Medicine (57 citations). Ester Amado has collaborated with scholars based in Spain. Frequent co-authors include Enriqueta Pujol‐Ribera, Josep M. Borràs, Pérez Rodríguez, Concepción Violán, José Luis del Val García, Valeria Pacheco‐Huergo, Albert Roso‐Llorach, Montserrat Núñez, Esther Núñez and Sergio Fernández‐Bertolín. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Medicine, BMC Public Health, Journal of Innovation in Health Informatics and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.